H6PD and cancer: Radiotherapy, which generates increased levels of ROS (48), increases G6PDH activity in cancer cells within 10 min of exposure, and this has been attributed to ROS-dependent ATM kinase activation and subsequent phosphorylation of Hsp27, which binds to G6PDH directly and enhances its activity (33).